Medical devices, healthcare technology and the business of care
PMA approval · P990019

BLU -U BLUE LIGHT PHOTODYNAMIC THERAPY ILLUMINATOR

Sun Pharmaceutical Industries, Inc. · Decision date Dec 3, 1999

FDA DECISIONP990019

What did the FDA approve?

FDA records P990019 as an original PMA application. The recorded decision is approval, dated Dec 3, 1999.

FDA approval order statement

The devices is indicated for use in Photodynamic Therapy with Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% for the treatment of non-hyperkeratotic actinic keratoses of the face or scalp.
Regulatory pathway
Original PMA
Clinical specialty
General, Plastic Surgery
Decision date
Dec 3, 1999

FDA source record

Regulatory record facts

Identifier
P990019
Regulatory pathway
Premarket approval application
Product code
MVF
Decision code
APPR
Decision date
Dec 3, 1999
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, laser, photodynamic therapy.

Product code
MVF
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P990019 received

    Application receipt date recorded by FDA.

  2. P990019 · FDA decision

    APPR

  3. P990019/S010 · Related supplement

    BLU-U Blue Light Photodynamic Therapy Illuminator (Model 4170E)

Timeline entries are records held by MedtechLedger for P990019. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P990019

Product / regulatory recordCompanyPathwayDecision dateSource
Sun Pharmaceutical Industries, Inc.PMA supplementNov 2, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Sun Pharmaceutical Industries, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
29 Dunham Rd., Billerica, MA, 01821

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records